All In Biotech

Drug Trial Radar · NCT05908825

Placebo-Controlled Study Assessing the Use of a Novel Exfoliative Serum With A Chemical Peel to Improve Photodamage in Adults

A Split-Face, Double-Blind, Placebo-Controlled Study Assessing the Use of a Novel Exfoliative Serum With A Chemical Peel to Improve Photodamage

Last checked: Nov 20, 2026Latest source record: Jul 19, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

34

Actual

Start

Jun 22, 2023

Primary completion

Nov 16, 2023

Study completion Jan 26, 2024

Sponsor

Lead sponsor
Austin Institute for Clinical ResearchResearch network
Sponsor type
Research network
Collaborators
SkinCeuticals
First posted
Jun 18, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Sequential
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 30 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a split-face, double-blind, placebo-controlled study assessing the use of a novel exfoliative serum with a chemical peel to improve photodamage in healthy female subjects between the ages of 30 and 65 years, inclusive, with Fitzpatrick skin types I-VI.

Conditions

  • Photodamaged Skin

Interventions

  • Vitamin C with AHA Exfoliative SerumDrug

    Catalyst is a novel skincare product comprised of low concentrations of multiple hydroxy acids and will be randomly assigned as Product A or Product B to be applied to one side of the face.

  • Placebo serumDrug

    Placebo serum will be randomly assigned as Product A or Product B to be applied to one side of the face.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Product tolerabilityTime frame: Change from Baseline at Day 42
  2. Change in Product efficacyTime frame: Change from Baseline at Day 42

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Austin Institute for Clinical Research, Inc.

    Pflugerville, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.